Skip to Main Content

Paper Details

Glutamate Is a Noninvasive Metabolic Biomarker of IDH1-Mutant Glioma Response to Temozolomide Treatment.
Cancer Res
13
2020
Author NameAffiliation
Joseph F CostelloHelen Diller Family Comprehensive Cancer Center, University of California San Francisco
  • 1 - 1

Datasets

Release 1.2